Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.86 INR | -4.22% | +1.24% | -1.30% |
Valuation
Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 322.4 | 375.3 | 237 | 137.7 | 185.5 | 449.6 |
Enterprise Value (EV) 1 | 318.6 | 364.6 | 231.5 | 147.1 | 209.5 | 491.8 |
P/E ratio | 27.7 x | 29.7 x | -32.3 x | 16.6 x | 22.6 x | 92.1 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.45 x | 0.56 x | 0.4 x | 0.24 x | 0.27 x | 0.67 x |
EV / Revenue | 0.44 x | 0.54 x | 0.39 x | 0.26 x | 0.3 x | 0.74 x |
EV / EBITDA | 17.2 x | 17.4 x | -34 x | 10.6 x | 11.7 x | 24.9 x |
EV / FCF | -119 x | 148 x | -141 x | -9.62 x | -25 x | -145 x |
FCF Yield | -0.84% | 0.68% | -0.71% | -10.4% | -4% | -0.69% |
Price to Book | 4.6 x | 4.53 x | 3.2 x | 1.64 x | 1.98 x | 4.63 x |
Nbr of stocks (in thousands) | 6,510 | 6,510 | 6,510 | 6,510 | 6,510 | 6,510 |
Reference price 2 | 49.52 | 57.65 | 36.40 | 21.15 | 28.50 | 69.06 |
Announcement Date | 5/23/18 | 9/3/19 | 11/19/20 | 9/4/21 | 9/7/22 | 9/6/23 |
Income Statement Evolution (Annual data)
Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 718.4 | 673 | 599.5 | 566.4 | 690.9 | 668.9 |
EBITDA 1 | 18.54 | 20.92 | -6.806 | 13.87 | 17.89 | 19.78 |
EBIT 1 | 16.51 | 18.67 | -9.729 | 11.14 | 15.45 | 16.55 |
Operating Margin | 2.3% | 2.77% | -1.62% | 1.97% | 2.24% | 2.47% |
Earnings before Tax (EBT) 1 | 16.54 | 18.9 | -11.68 | 9.244 | 12.62 | 6.745 |
Net income 1 | 11.64 | 12.63 | -7.327 | 8.319 | 8.225 | 4.893 |
Net margin | 1.62% | 1.88% | -1.22% | 1.47% | 1.19% | 0.73% |
EPS 2 | 1.788 | 1.940 | -1.125 | 1.278 | 1.260 | 0.7500 |
Free Cash Flow 1 | -2.681 | 2.465 | -1.646 | -15.29 | -8.385 | -3.381 |
FCF margin | -0.37% | 0.37% | -0.27% | -2.7% | -1.21% | -0.51% |
FCF Conversion (EBITDA) | - | 11.78% | - | - | - | - |
FCF Conversion (Net income) | - | 19.51% | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 5/23/18 | 9/3/19 | 11/19/20 | 9/4/21 | 9/7/22 | 9/6/23 |
Balance Sheet Analysis
Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 9.39 | 24 | 42.3 |
Net Cash position 1 | 3.77 | 10.7 | 5.48 | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | 0.6764 x | 1.339 x | 2.137 x |
Free Cash Flow 1 | -2.68 | 2.47 | -1.65 | -15.3 | -8.39 | -3.38 |
ROE (net income / shareholders' equity) | 18.2% | 16.5% | -9.34% | 10.5% | 9.17% | 5.14% |
ROA (Net income/ Total Assets) | 3.27% | 3.61% | -1.77% | 2.11% | 2.76% | 2.54% |
Assets 1 | 356.3 | 350.4 | 415 | 395 | 298.5 | 192.5 |
Book Value Per Share 2 | 10.80 | 12.70 | 11.40 | 12.90 | 14.40 | 14.90 |
Cash Flow per Share 2 | 1.890 | 2.560 | 3.220 | 2.550 | 2.320 | 2.490 |
Capex 1 | 0.33 | 3.91 | 0.53 | 6.15 | 0.27 | 15.5 |
Capex / Sales | 0.05% | 0.58% | 0.09% | 1.09% | 0.04% | 2.31% |
Announcement Date | 5/23/18 | 9/3/19 | 11/19/20 | 9/4/21 | 9/7/22 | 9/6/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-1.30% | 3.33M | |
+27.33% | 76.24B | |
+13.87% | 8.76B | |
-3.37% | 8.17B | |
-36.08% | 6.63B | |
+21.98% | 5.53B | |
+2.75% | 4.13B | |
-7.61% | 3.8B | |
-11.12% | 3.32B | |
+7.96% | 3.2B |
- Stock Market
- Equities
- ZENLABS6 Stock
- Financials Zenlabs Ethica Limited